Type 2 diabetes mellitus boosts risk of pancreatic cancer
By David Liu PHD
Sunday Jan 1, 2012 (foodconsumer.org) -- A review first published online Dec 12, 2011 in Molecular Carcinogenesis says that type 2 diabetes mellitus is likely an important modifiable risk factor for pancreatic cancer, in addition to cigarette smoking and obesity.
Dr. Donghui Li, the author of the review, at The University of Texas MD Anderson Cancer Center in Houston, Texas says in his report the risk for pancreatic cancer in people with type 2 diabetes mellitus is 50 to 100 percent higher than those who do not have the disease, as early epidemiological studies showed.
This is not just an association, Li says. Evidence suggests type 2 diabetes mellitus can be a cause for pancreatic cancer. The possible mechanisms behind the association between type 2 diabetes and pancreatic cancer may involve insulin resistance, and associated hyperglycemia, hyperinsulinemia, and inflammation. But is is unclear what is exactly behind both diabetes and pancreatic cancer.
Another factor that affects the risk of pancreatic cancer is use of the antidiabetic drug metformin, which reduces the risk of pancreatic cancer when it is used in patients with type 2 diabetes mellitus. This means drugs like metformin may potentially be used to prevent pancreatic cancer.
Further, new-onset diabetes may be linked to increased odds of early diagnosis of sub-clinical pancreatic cancer.
Pancreatic cancer is the most lethal malignancy, which is diagnosed in 44,030 people in the United States in 2011 and the disease kills about 37,660 in 2011 in the country.
Type 2 diabetes mellitus is believed to affect 26 million Americans.
(Send your news to firstname.lastname@example.org, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
- Actor Channing Tatum to Appear at Amazonian Beverage Maker RUNA's Booth at Natural Products Expo West
- Stillbirth may increase women's long term risk for depression
- One bad apple…
- Elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence
- Carnitine supplements help metabolic symdrome
Rate this article